Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Imunon, Inc.IMNN · Entity 8041 | Chief Medical Officer | October 09, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Imunon, Inc.
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,927 |
Reported balance
After 2026-10-09 transaction · row 1
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 1,249 · Balance 46,927 F1: Stock granted in lieu of cash for portion of base salary |
Filing footnotes · ownership attribution and instrument terms
F1: Stock granted in lieu of cash for portion of base salary
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 20:05 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 1,249 | $1.08 | $1,348.92 |
DisclosureSEC source: 0001437749-26-032560 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,927 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 25, 2026 Filed Sep 28, 2026 20:29 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 4,390 | $1.41 | $6,189.90 |
DisclosureSEC source: 0001437749-26-031360 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,678 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 16:41 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 4,211 | $1.47 | $6,190.17 |
DisclosureSEC source: 0001437749-26-030413 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,288 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:07 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 3,626 | $1.60 | $5,801.60 |
DisclosureSEC source: 0001437749-26-029407 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,077 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:21 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 3,516 | $1.65 | $5,801.40 |
DisclosureSEC source: 0001437749-26-028186 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,451 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:11 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 3,649 | $1.59 | $5,801.91 |
DisclosureSEC source: 0001437749-26-025658 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,935 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 20:15 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 3,082 | $1.83 | $5,640.06 |
DisclosureSEC source: 0001437749-26-023947 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,286 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:56 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 1,308 | $1.91 | $2,498.28 |
DisclosureSEC source: 0001437749-26-022943 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,204 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:35 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 21,896 | $1.72 | $37,661.12 |
DisclosureSEC source: 0001437749-26-022009 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,896 F1 · shares: Stock granted in lieu of cash for 50% of 2025 annual cash bonus Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:08 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 12,667 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001437749-26-000610 · rdgdoc.xml · derivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,667 Underlying: Common Stock · 12,667 shares Expires 2036-01-02 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:17 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-25-004366 · rdgdoc.xml · derivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-18 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject to the grantee's continued service as an employee through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.